Atlas Trials

Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease

Clinical trial NCT01137955 · COMPLETED

Trial details

NCT number
NCT01137955
Sponsor
Columbia University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Celiac Disease
Start date
2006-10-01
Primary completion
2008-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.